Evidence map›Paper›PMID 33568513›Full record

ArticleJournal of virology2021

Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.

Benjamin E Nilsson-Payant, Daniel Blanco-Melo, Skyler Uhl, Beatriz Escudero-Pérez, Silke Olschewski, Patricia Thibault, Maryline Panis, Maria Rosenthal, César Muñoz-Fontela, Benhur Lee and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Unraveling the complexities of neurotropic virus infection and immune evasion.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  5. Article
  6. Review
  7. Negative and ambisense RNA virus ribonucleocapsids: more than protective armor.Microbiology and molecular biology reviews : MMBR · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Benjamin E Nilsson-Payant *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0003-2661-7837
Daniel Blanco-Melo *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-0256-5019
Skyler UhlDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0001-8517-1455
Beatriz Escudero-PérezBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.ORCID 0000-0003-3655-0525
Silke OlschewskiBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Patricia ThibaultDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-7313-0848
Maryline PanisDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Maria RosenthalBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.ORCID 0000-0003-2986-936X
César Muñoz-FontelaBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.ORCID 0000-0002-7725-2586
Benhur LeeDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0003-0760-1709
Benjamin R tenOeverDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA benjamin.tenoever@mssm.edu.ORCID 0000-0003-0324-3078
Icahn School of Medicine at Mount Sinai · USBernhard Nocht Institute for Tropical Medicine · DEGerman Center for Infection Research · DEGlobal Virus Network · US

Funding

Tropism, pathogenicity, and potential for zoonotic spillover of emergent henipa- and henipa-like virusesR01AI123449 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LEE, BENHUR · 2016 to 2020
$2.7M
SUMO and ubiquitin modifications in henipavirus matrix trafficking and functionR01AI125536 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LEE, BENHUR · 2016 to 2020
$2.1M
Functional interrogation of paramyxovirus genomes with efficient reverse geneticsR21AI115226 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LEE, BENHUR · 2015 to 2016
$460k
CIHRNIAID NIH HHS R01 AI123449NIAID NIH HHS R01 AI125536NIAID NIH HHS R21 AI115226
6 · The paper itself

Abstract

Negative-sense RNA viruses (NSVs) rely on prepackaged viral RNA-dependent RNA polymerases (RdRp) to replicate and transcribe their viral genomes. Their replication machinery consists of an RdRp bound to viral RNA which is wound around a nucleoprotein (NP) scaffold, forming a viral ribonucleoprotein complex. NSV NP is known to regulate transcription and replication of genomic RNA; however, its role in maintaining and protecting the viral genetic material is unknown. Here, we exploited host microRNA expression to target NP of influenza A virus and Sendai virus to ascertain how this would impact genomic levels and the host response to infection. We find that in addition to inducing a drastic decrease in genome replication, the antiviral host response in the absence of NP is dramatically enhanced. Additionally, our data show that insufficient levels of NP prevent the replication machinery of these NSVs to process full-length genomes, resulting in aberrant replication products which form pathogen-associated molecular patterns in the process. These dynamics facilitate immune recognition by cellular pattern recognition receptors leading to a strong host antiviral response. Moreover, we observe that the consequences of limiting NP levels are universal among NSVs, including Ebola virus, Lassa virus, and measles virus. Overall, these results provide new insights into viral genome replication of negative-sense RNA viruses and highlight novel avenues for developing effective antiviral strategies, adjuvants, and/or live-attenuated vaccines.

Indexed as

Virus ReplicationA549 CellsAnimalsChlorocebus aethiopsDogsHEK293 CellsHeLa CellsHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMadin Darby Canine Kidney CellsNucleocapsid ProteinsRespirovirus InfectionsSendai virusVero CellsViral TropismNucleocapsid ProteinsarenavirusfilovirusIFN responseinfluenzainnate immunitymiRNAnegative-strand RNA virusparamyxovirusviral replication

Identifiers

PMID33568513
PMCPMC8104106
OpenAlexW3126366424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.